Effects of Two Different Eye Care Practices on Eye Complications in Mechanically Ventilated Intensive Care Patients
Launched by ISTANBUL SAGLIK BILIMLERI UNIVERSITY · Jul 8, 2025
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying different ways to care for the eyes of patients who are in the intensive care unit (ICU) and need help breathing with a machine called a ventilator. When people are on a ventilator, their eyes can sometimes develop problems because they may not blink or close their eyes properly. The study will compare four types of eye care: the usual care, care using a special eye care kit, care following a detailed eye care plan (called a protocol), and care that combines both the kit and the plan. The goal is to find out which method is best at preventing eye problems in these patients.
To take part, patients must be adults (18 years or older), on a ventilator, have a certain level of reduced consciousness, and have been in the ICU for at least a day. They also need to have enough natural tear production to protect their eyes before joining the study. Patients with brain death, recent head or eye injuries, brain surgery, or existing eye infections won’t be included. If someone agrees to participate, their eye care will be managed using one of the four methods, and the researchers will watch closely to see how well each method prevents eye complications. This study is not yet recruiting participants, but it aims to help improve eye care for critically ill patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 years or older
- • Receiving mechanical ventilation
- • Glasgow Coma Scale (GCS) score \< 12
- • At least 24 hours have passed since ICU admission
- • Baseline Schirmer test result indicating tear production \> 5 mm prior to study inclusion
- Exclusion Criteria:
- • Diagnosed with brain death
- • Presence of facial or ocular trauma
- • Patients with head trauma
- • Patients who have undergone brain surgery
- • Patients diagnosed with an eye infection or chemosis
- Withdrawal Criteria:
- • Patient's death during the study period
- • Extubation of the patient before completion of the care period
About Istanbul Saglik Bilimleri University
Istanbul Sağlık Bilimleri University is a prominent academic institution dedicated to advancing healthcare through innovative research and education. As a clinical trial sponsor, the university leverages its expertise in health sciences to facilitate rigorous clinical studies aimed at improving patient outcomes and contributing to the body of medical knowledge. With a commitment to ethical practices and collaboration, Istanbul Sağlık Bilimleri University fosters an environment that encourages scientific inquiry and the translation of research findings into practical applications, thereby enhancing the quality of healthcare both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Trial Officials
Yildiz Deniz
Principal Investigator
University of Health Sciences (Sağlık Bilimleri Üniversitesi)
Besey Oren
Study Director
University of Health Sciences (Sağlık Bilimleri Üniversitesi)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported